Filing Details
- Accession Number:
- 0001181431-12-011208
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-23 16:29:05
- Reporting Period:
- 2012-02-21
- Filing Date:
- 2012-02-23
- Accepted Time:
- 2012-02-23 16:29:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1183765 | Threshold Pharmaceuticals Inc | THLD | Pharmaceutical Preparations (2834) | 943409596 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1456654 | Fhm Vi, L.l.c. | 601 Union Street, Suite 3200 Seattle WA 98101 | No | No | Yes | No | |
1456655 | Fhm Vi, L.p. | 601 Union Street, Suite 3200 Seattle WA 98101 | No | No | Yes | No | |
1456656 | Frazier Healthcare Vi, L.p. | 601 Union Street, Suite 3200 Seattle WA 98101 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-02-21 | 1,028,842 | $5.38 | 3,550,239 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2012-02-21 | 1,028,842 | $5.38 | 3,550,239 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2012-02-21 | 1,028,842 | $5.38 | 3,550,239 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-21 | 3,550,239 | $6.02 | 0 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2012-02-21 | 3,550,239 | $6.02 | 0 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2012-02-21 | 3,550,239 | $6.02 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Direct | |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Direct |
Footnotes
- These shares were sold by Frazier Healthcare VI, L.P. ("FH VI"). FHM VI, L.L.C. ("FHM VI L.L.C.") is the general partner of FHM VI., L.P. ("FHM VI"), which is the general partner of FH VI. FHM VI L.L.C. may be deemed to have voting and dispositive power with respect to the securities held by FH VI. FHM VI L.L.C. disclaims beneficial ownership of the securities held by FH VI except to the extent of any pecuniary interest therein.
- These shares were sold by FH VI. FHM VI is the general partner of FH VI and may be deemed to have voting and dispositive power with respect to the securities held by FH VI. FHM VI disclaims beneficial ownership of the securities held by FH VI except to the extent of any pecuniary interest therein.
- These shares were sold by FH VI.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.98 to $5.98, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.985 to $6.465, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.